2011
DOI: 10.1016/j.clon.2011.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Late-onset Bowel Dysfunction after Pelvic Radiotherapy: A National Survey of Current Practice and Opinions of Clinical Oncologists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(16 citation statements)
references
References 13 publications
0
16
0
Order By: Relevance
“…In agreement with our findings, Henson et al showed that late-onset bowel dysfunction can pose a significant problem after pelvic radiotherapy, emphasizing that clinical oncologists be aware of such possibilities. 11 In our study, patients with late-onset complications demonstrated poorer complication resolution outcomes. In contrast, Zucali et al reported that the side effects of radiotherapy were moderate and transient and that no late-onset small bowel complications were observed; however, the follow-up period in that study was ,10 years.…”
Section: Discussionmentioning
confidence: 71%
“…In agreement with our findings, Henson et al showed that late-onset bowel dysfunction can pose a significant problem after pelvic radiotherapy, emphasizing that clinical oncologists be aware of such possibilities. 11 In our study, patients with late-onset complications demonstrated poorer complication resolution outcomes. In contrast, Zucali et al reported that the side effects of radiotherapy were moderate and transient and that no late-onset small bowel complications were observed; however, the follow-up period in that study was ,10 years.…”
Section: Discussionmentioning
confidence: 71%
“…A recent national survey of U.K. Clinical Oncologists established that although late adverse effects following pelvic radiotherapy are gradually being recognised, there is a lack of specialist services for patients with late-onset bowel dysfunction (Henson et al, 2011). As cancer treatments evolve and we learn more about the risk factors associated with the consequences of treatment there is a need for more individually targeted follow-up and support.…”
Section: Discussionmentioning
confidence: 97%
“…It is estimated that in the United States, w300,000 patients/y receive radiotherapy for pelvic or abdominal malignancies (1,2). In the United Kingdom, an estimated 17,000 patients/y receive radical (curative) radiotherapy (3). Despite major advances in radiotherapy techniques, radiation-induced gastrointestinal toxicity is common.…”
Section: Introductionmentioning
confidence: 99%